19264 Federal Register / Vol. 60, No. 73 / Monday, April 17, 1995 / Notices

Centers for Disease Control and

Prevention

Technical Advisory Committee for

Diabetes Translation and Community

Control Programs: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Technical Advisory Committee for

Diabetes Translation and Community Control

Programs.

Times and Dates: 1 p.m.–5 p.m., Thursday,

May 4, 1995. 8 a.m.–11:30 a.m., Friday, May

5, 1995.

Place: Adam’s Mark Hotel, Vail Room,

1550 Court Place, Denver, Colorado 80202–

5199, telephone 303/893–3333.

Status: Open to the public, limited only by

the space available.

Purpose: This committee is charged with

advising the Director, CDC, regarding

priorities and feasible goals for translation

activities and community control programs

designed to reduce risk factors, morbidity,

and mortality from diabetes and its

complications. The committee advises

regarding policies, strategies, goals and

objectives, and priorities; identifies research

advances and technologies ready for

translation into widespread community

practice; recommends public health

strategies to be implemented through

community interventions; advises on

operational research and outcome evaluation

methodologies; identifies research issues for

further clinical investigation; and advises

regarding the coordination of programs with

Federal, voluntary, and private resources

involved in the provision of services to

people with diabetes.

Matters To Be Discussed: Committee

members will discuss progress towards a

National Diabetes Education Program,

evolving strategies and scientific activities

related to screening for Type II diabetes,

possible participation by CDC in the National

Institutes of Health-sponsored Diabetes

Prevention Trial-Type II, policy and

economic activities, and the status of

mechanisms of CDC’s Division of Diabetes

Translation support to States.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Cheryl Shaw, Program Specialist, Division of

Diabetes Translation, National Center for

Chronic Disease Prevention and Health

Promotion, CDC, 4770 Buford Highway, NE,

Mailstop K–10, Atlanta, Georgia 30341–3724,

telephone 404/488–5004.

Dated: April 11, 1995.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–9336 Filed 4–14–95; 8:45 am]

BILLING CODE 4163–18–M

Advisory Committee for EnergyRelated Epidemiologic Research:

Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Advisory Committee for EnergyRelated Epidemiologic Research.

Times and Dates: 9 a.m.–5 p.m., May 4,

1995; 9 a.m.–12 noon, May 5, 1995.

Place: Sheraton Suites Hotel, 801 North St.

Asaph Street, Alexandria, Virginia 22314.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 50 people.

Purpose: This committee is charged with

providing advice and recommendations to

the Secretary of Health and Human Services

(HHS); the Assistant Secretary for Health; the

Director, CDC; and the Administrator,

Agency for Toxic Substances and Disease

Registry, on the establishment of a research

agenda and the conduct of a research

program pertaining to energy-related analytic

epidemiologic studies. The committee will

take into consideration information and

proposals provided by the Department of

Energy (DOE), the Advisory Committee for

Environment Safety and Health which was

established by DOE under the guidelines of

a Memorandum of Understanding between

HHS and DOE, and other agencies and

organizations, regarding the direction HHS

should take in establishing the research plan

and in the development of a research plan.

Matters To Be Discussed: The committee

will discuss working group

recommendations, environmental data and

research methods, the research agenda, and

public involvement activities. Presentations

will be made by DOE on the Conference on

Epidemiologic Data Resources and

occupational surveillance plans and progress.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Nadine Dickerson, Program Analyst,

Radiation Studies Branch, Division of

Environmental Hazards and Health Effects,

National Center for Environmental Health,

CDC, 4770 Buford Highway NE., Mailstop F–

35, Atlanta, Georgia 30341–3724; telephone

404/488–7040.

Dated: April 11, 1995.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–9337 Filed 4–14–95; 8:45 am]

BILLING CODE 4163–18–M

Board of Scientific Counselors,

National Center for Infectious

Diseases: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Board of Scientific Counselors,

National Center for Infectious Diseases

(NCID).

Times and Dates: 8:30 a.m.–5 p.m., May 4,

1995; 8:15 a.m.–1:15 p.m., May 5, 1995.

Place: CDC, Auditorium B, 1600 Clifton

Road, NE, Atlanta, Georgia 30333.

Status: Open to the public, limited only by

the space available.

Purpose: The Board of Scientific

Counselors, NCID, provides advice and

guidance to the Director, CDC, and Director,

NCID, in the following areas: program goals

and objectives; strategies; program

organization and resources for infectious

disease prevention and control; and program

priorities.

Matters To Be Discussed: The agenda will

focus on:

1. Update: Implementation of CDC

Emerging Infections Plan.

2. CDC Laboratories Master Plan.

3. Linkages between HIV/Sexually

Transmitted Diseases/Tuberculosis

Laboratories and Programs in other

Centers.

4. Fiscal Year (FY) 1995 Budget Rescissions

and FY 1996 Budget Outlook.

5. The CDC Foundation.

6. Update—Antibiotic Resistance.

Other agenda items include

announcements/introductions; NCID update;

late breakers; and follow-up on actions

recommended by the board (December 1994).

Agenda items are subject to change as

priorities dictate.

Written comments are welcome and should

be received by the contact person listed

below prior to the opening of the meeting.

Contact Person for More Information:

Diane S. Holley, Office of the Director, NCID,

CDC, Mailstop C–20, 1600 Clifton Road, NE,

Atlanta, Georgia 30333, telephone 404/639–

0078.

Dated: April 11, 1995.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–9335 Filed 4–14–95; 8:45 am]

BILLING CODE 4163–18–M

Food and Drug Administration

[Docket No. 95N–0098]

Drug Export; Vironostika HTLV–I/II

Microelisa System

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Organon Teknika Corp. has filed an

application requesting approval for the

export of the human biological product

Vironostika HTLV–I/II Microelisa

System to The Netherlands.